Side-by-side financials for EDIT and ARGX. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EDIT | ARGX |
|---|---|---|
| Market cap | - | $55.29 B |
| US-listed rank | - | #303 |
| Revenue (latest FY) | $40.52M | - |
| Net income (latest FY) | -$160.06M | - |
| Net margin | -395.0% | - |
| SEC filings | 693 | 272 |
Full pages: Editas Medicine, Inc. and ARGENX SE, or browse the full rankings.